Study Conduct

Astrazeneca, University of Cambridge form joint Ph.D., clinical research scholarships

Wednesday, July 1, 2015 10:11 AM

AstraZeneca and the University of Cambridge have formed three new joint schemes to support more than 80 Ph.D. scholarships and eight clinical lectureships over the next five years, spanning translational science, basic and clinical research.

More... »


Claritas Genomics, Genetic Alliance partner on patients’ results sharing

Wednesday, June 24, 2015 10:38 AM

Claritas Genomics, a Cambridge, Mass.-based genetic diagnostic laboratory, and Genetic Alliance, a nonprofit health advocacy organization based in Wash. D.C., announced a partnership to help patients and families find and participate in relevant research opportunities that will advance understanding of individual genetic disorders and development of new therapies.

More... »


FDA, TransCelerate, INC Research to speak at 10th Annual Global Site Solutions Summit

Wednesday, June 24, 2015 10:11 AM

The Society for Clinical Research Sites (SCRS), a global trade organization representing the interests of clinical research sites, has announced an invigorated, solution-driven program for the 10th Annual Global Site Solutions Summit. The Summit will be Oct. 8-11, in Amelia Island, Fla. The annual meeting, which attracts investigators, site executives and industry executives from around the globe, is inclusive of interactive sessions, knowledge and best practice sharing, and networking opportunities, centered around the collaboration-focused theme “Better Together.”

More... »

BIA responds to Jim O’Neill’s review on antimicrobial resistance

Monday, June 22, 2015 09:54 AM

The U.K. Bioindustry Association (BIA) has submitted its initial response to Jim O’Neill’s review on antimicrobial resistance (AMR), focusing on his interim report Securing new drugs for future generations: The antibiotics pipeline, published in May. Steve Bates, CEO of the BIA, put forward the case that any new economic model should be based on an informed stewardship not restrictive stewardship approach.

More... »

U.S. Oncology Research, Cure Forward collaborate

Friday, June 19, 2015 11:32 AM

U.S. Oncology Research, a network of integrated, community-based oncology practices dedicated to advancing high-quality treatments through clinical trials, has inked a collaboration with Cure Forward, a patient activation company. U.S. Oncology Research and Cure Forward will work together to make personalized medicine more accessible and approachable in the community setting, reinforcing the cooperation that exists between physicians and patients through educational resources and improved clinical trial matching.

More... »

Pharmatech launches recruiting solution CureAcess.com, Just-In-Time model

Friday, June 19, 2015 10:47 AM

Pharmatech, a Denver-based oncology CRO, is changing how clinical trials studies enroll cancer patients by offering a patient-centered, on-demand research alternative. Pharmatech helps cancer patients identify the right trial opportunity, then activates that trial at a nearby treatment center using a Just-In-Time delivery model.

More... »

ICON launches Firecrest Patient Portal to enhance informed consent education

Friday, June 19, 2015 10:38 AM

Global CRO Icon has launched the Firecrest Patient Portal. This portal enables patients to view clinical trial information and is specifically designed to enhance the patients’ understanding of treatment before consenting to participate at an investigator site.

More... »

Society for Clinical Research Sites launches program for Asia-Pac Site Solutions Summit

Wednesday, June 17, 2015 08:30 AM

The Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites, has announced a program for the 2015 Asia-Pac Site Solutions Summit. The Asia-Pac Site Solutions Summit will be July 30-31, 2015 in Melbourne, Australia. The Summit is open to clinical research investigators, site executives and industry stakeholders.

More... »

CTTI issues new recommendations to improve quality in clinical trials

Monday, June 15, 2015 01:31 PM

The Clinical Trials Transformation Initiative (CTTI), a public-private partnership to identify practices to increase the quality and efficiency of clinical trials based in Durham, N.C., has issued recommendations to improve the quality and efficiency of clinical trials by helping sponsors focus on study activities that are essential to the safety of trial participants and the reliability of study results, and to reduce or eliminate those activities that are not. 

More... »

Mosio launches suite of patient recruitment and retention solutions

Monday, June 15, 2015 01:15 PM

Mosio, a San Francisco, Calif.-based life science technology company, has launched a suite of solutions created specifically for each type of organization within the clinical research ecosystem. Mosio’s web-based mobile messaging software services to enhance clinical trial recruitment and retention range from targeted plans for principal investigators and study sites to broad capabilities for CROs and fully customizable solutions for integration into study platforms of study sponsors, patient recruitment firms and trial technology enterprises.

More... »

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs